Klinisch-Molekularbiologisches Forschungszentrum


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Erratum to: Induction of initial steps of angiogenic differentiation and maturation of endothelial cells by pericytes in vitro and the role of collagen IV (2016) Zhou Z, Pausch F, Schlötzer-Schrehardt U, Brachvogel B, Poeschl E Journal article, Erratum Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression (2016) Shvab A, Haase G, Ben-Shmuel A, Gavert N, Brabletz T, Dedhar S, Ben-Ze'Ev A Journal article Functional consequence of fibulin-4 missense mutations associated with vascular and skeletal abnormalities and cutis laxa (2016) Sasaki T, Hanisch FG, Deutzmann R, Sakai LY, Sakuma T, Miyamoto T, Yamamoto T, et al. Journal article MYC-nick promotes cell migration by inducing fascin expression and Cdc42 activation (2016) Anderson S, Poudel KR, Roh-Johnson M, Brabletz T, Yu M, Borenstein-Auerbach N, Grady WN, et al. Journal article Screening for Acromegaly in Patients with Carpal Tunnel Syndrome: A Prospective Study (ACROCARP) (2016) Zoicas F, Kleindienst A, Mayr B, Buchfelder M, Megele R, Schöfl C Journal article Activating Calcium-Sensing Receptor Mutations: Prospects for Future Treatment with Calcilytics (2016) Mayr B, Glaudo M, Schöfl C Journal article The MID1 protein is a central player during development and in disease (2016) Winter J, Basilicata MF, Stemmler M, Krauss S Journal article The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5 (2015) Sundararajan V, Gengenbacher N, Stemmler M, Kleemann J, Brabletz T, Brabletz S Journal article The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors (2015) Mock K, Preca BT, Brummer T, Brabletz S, Stemmler M, Brabletz T Journal article ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat (2015) Meidhof S, Brabletz S, Lehmann W, Preca BT, Mock K, Ruh M, Schueler J, et al. Journal article